Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 16 studies | 46% ± 17% | |
| mesothelial cell | 3 studies | 31% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 33% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 97% | 1801.64 | 636 / 653 | 96% | 29.58 | 579 / 605 |
| brain | 98% | 10596.58 | 2587 / 2642 | 86% | 44.19 | 609 / 705 |
| muscle | 95% | 3944.37 | 764 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 88% | 1280.56 | 1174 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 70% | 1457.17 | 251 / 359 | 11% | 0.78 | 32 / 286 |
| heart | 79% | 1157.84 | 676 / 861 | 0% | 0 | 0 / 0 |
| ovary | 18% | 144.28 | 32 / 180 | 58% | 3.42 | 248 / 430 |
| spleen | 52% | 377.02 | 126 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 3.52 | 15 / 29 |
| pancreas | 0% | 1.88 | 1 / 328 | 43% | 2.92 | 76 / 178 |
| adipose | 42% | 1493.25 | 505 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 12% | 89.69 | 173 / 1445 | 16% | 1.07 | 30 / 183 |
| lung | 8% | 84.44 | 46 / 578 | 19% | 0.97 | 221 / 1155 |
| uterus | 10% | 78.46 | 17 / 170 | 14% | 1.22 | 65 / 459 |
| prostate | 5% | 48.02 | 12 / 245 | 16% | 0.50 | 82 / 502 |
| breast | 7% | 53.27 | 34 / 459 | 12% | 0.48 | 136 / 1118 |
| peripheral blood | 17% | 146.46 | 158 / 929 | 0% | 0 | 0 / 0 |
| intestine | 7% | 46.92 | 68 / 966 | 10% | 0.71 | 52 / 527 |
| liver | 0% | 2.50 | 1 / 226 | 12% | 1.54 | 48 / 406 |
| skin | 1% | 6.36 | 14 / 1809 | 7% | 0.31 | 34 / 472 |
| bladder | 0% | 0 | 0 / 21 | 6% | 0.26 | 32 / 504 |
| kidney | 2% | 16.84 | 2 / 89 | 3% | 0.13 | 28 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.18 | 2 / 45 |
| adrenal gland | 0% | 0 | 0 / 258 | 2% | 0.30 | 4 / 230 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006548 | Biological process | L-histidine catabolic process |
| GO_0035499 | Biological process | carnosine biosynthetic process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005829 | Cellular component | cytosol |
| GO_0102102 | Molecular function | homocarnosine synthase activity |
| GO_0047730 | Molecular function | carnosine synthase activity |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | CARNS1 |
| Protein name | Carnosine synthase 1 (EC 6.3.2.11) (ATP-grasp domain-containing protein 1) |
| Synonyms | ATPGD1 KIAA1394 |
| Description | FUNCTION: Catalyzes the synthesis of carnosine and homocarnosine. Carnosine is synthesized more efficiently than homocarnosine. . |
| Accessions | ENST00000687366.1 [A5YM72-5] ENST00000531040.5 [A5YM72-4] ENST00000307823.7 [A5YM72-1] ENST00000445895.2 [A5YM72-5] A5YM72 |